Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Galit Alter

Showing results (171-180 of 534) with videos related to

Pageof 54
Sort By:
Cell Reports. Medicine|March 15, 2023
Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccinationCarolyn M Boudreau, John S Burke, Alexander L Roederer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?Rasmi Thomas, Eriko Yamada, Galit Alter, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2020
Distinct Human NK Cell Phenotypes and Functional Responses to <i>Mycobacterium tuberculosis</i> in Adults From TB Endemic and Non-endemic RegionsLevelle D Harris, Jeremiah Khayumbi, Joshua Ongalo, et al.
Science Immunology|February 24, 2019
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytesJulie M Fox, Vicky Roy, Bronwyn M Gunn, et al.
Ebiomedicine|March 4, 2023
Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 countsMaphe Mthembu, Kathryn A Bowman, Leela R L Davies, et al.
Cell Reports|November 26, 2023
Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccinesYixiang Deng, Caroline Atyeo, Dansu Yuan, et al.
Plos Pathogens|April 10, 2018
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodiesSimone I Richardson, Amy W Chung, Harini Natarajan, et al.
Cell Reports|February 9, 2022
Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trialCarolyn M Boudreau, John S Burke, Kiel D Shuey, et al.
Frontiers in Immunology|October 11, 2021
A <i>Mycobacterium tuberculosis</i> Specific IgG3 Signature of Recurrent TuberculosisStephanie Fischinger, Deniz Cizmeci, Sally Shin, et al.
AIDS (London, England)|November 16, 2010
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccineLaura Papagno, Galit Alter, Lambert Assoumou, et al.
Pageof 54

Showing results (171-180 of 534) with videos related to

Sort By:
Pageof 54
Cell Reports. Medicine|March 15, 2023
Pre-existing Fc profiles shape the evolution of neutralizing antibody breadth following influenza vaccinationCarolyn M Boudreau, John S Burke, Alexander L Roederer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?Rasmi Thomas, Eriko Yamada, Galit Alter, et al.
Frontiers in Cellular and Infection Microbiology|April 9, 2020
Distinct Human NK Cell Phenotypes and Functional Responses to <i>Mycobacterium tuberculosis</i> in Adults From TB Endemic and Non-endemic RegionsLevelle D Harris, Jeremiah Khayumbi, Joshua Ongalo, et al.
Science Immunology|February 24, 2019
Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytesJulie M Fox, Vicky Roy, Bronwyn M Gunn, et al.
Ebiomedicine|March 4, 2023
Discrepancy between Mtb-specific IFN-γ and IgG responses in HIV-positive people with low CD4 countsMaphe Mthembu, Kathryn A Bowman, Leela R L Davies, et al.
Cell Reports|November 26, 2023
Beta-spike-containing boosters induce robust and functional antibody responses to SARS-CoV-2 in macaques primed with distinct vaccinesYixiang Deng, Caroline Atyeo, Dansu Yuan, et al.
Plos Pathogens|April 10, 2018
HIV-specific Fc effector function early in infection predicts the development of broadly neutralizing antibodiesSimone I Richardson, Amy W Chung, Harini Natarajan, et al.
Cell Reports|February 9, 2022
Dissecting Fc signatures of protection in neonates following maternal influenza vaccination in a placebo-controlled trialCarolyn M Boudreau, John S Burke, Kiel D Shuey, et al.
Frontiers in Immunology|October 11, 2021
A <i>Mycobacterium tuberculosis</i> Specific IgG3 Signature of Recurrent TuberculosisStephanie Fischinger, Deniz Cizmeci, Sally Shin, et al.
AIDS (London, England)|November 16, 2010
Comprehensive analysis of virus-specific T-cells provides clues for the failure of therapeutic immunization with ALVAC-HIV vaccineLaura Papagno, Galit Alter, Lambert Assoumou, et al.
Pageof 54